US2008108052A1PendingUtilityA1

Use of Ribozymes in the Detection of Adventitious Agents

69
Assignee: ONCOLYTICS BIOTECH INCPriority: Feb 28, 2002Filed: Mar 27, 2007Published: May 8, 2008
Est. expiryFeb 28, 2022(expired)· nominal 20-yr term from priority
C12Q 2521/337C12N 15/1131C12Q 1/04C12Q 1/701C12N 2310/121
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a method of detecting adventitious agents in a composition comprising a microorganism by using ribozyme-expressing indicator cells, as well as indicator cells useful in such detection.

Claims

exact text as granted — not AI-modified
1 - 31 . (canceled) 
     
     
         32 . A method of detecting the presence of an adventitious agent in a therapeutic composition comprising a reovirus, the method comprising the steps of:
 (a) providing a population of indicator cells that expresses a ribozyme, wherein the ribozyme is capable of specifically cleaving the genome of the reovirus;   (b) contacting the indicator cells with the therapeutic composition comprising a reovirus under conditions that allow for cleavage of the genome of the reovirus by the ribozyme; and   (c) detecting the presence or absence of a pathogenic effect on the indicator cells contacted with the therapeutic composition, wherein the presence of a pathogenic effect indicates the presence of an adventitious agent in the therapeutic composition.   
     
     
         33 . The method of claim  1  wherein the indicator cells express the ribozyme from a gene that is integrated into the genome of the cells. 
     
     
         34 . The method of claim  1  wherein the ribozyme is capable of specifically cleaving the sl RNA of the reovirus. 
     
     
         35 . The method of claim  1  wherein the ribozyme is Rz-553 or Rz-984. 
     
     
         36 . The method of claim  1  wherein the reovirus is a mammalian reovirus or a human reovirus. 
     
     
         37 . The method of claim  1  wherein the reovirus is a serotype 3 reovirus. 
     
     
         38 . The method of claim  1  wherein the reovirus is a recombinant reovirus. 
     
     
         39 . The method of claim  1 , wherein the population of indicator cells comprises human cells. 
     
     
         40 . The method of claim  1 , wherein the adventitious agent is an infectious agent, other than reovirus, which is capable of infecting the indicator cell.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.